BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 28007998)

  • 1. Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome.
    Kanaan AS; Gerasch S; García-García I; Lampe L; Pampel A; Anwander A; Near J; Möller HE; Müller-Vahl K
    Brain; 2017 Jan; 140(1):218-234. PubMed ID: 28007998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome.
    Worbe Y; Marrakchi-Kacem L; Lecomte S; Valabregue R; Poupon F; Guevara P; Tucholka A; Mangin JF; Vidailhet M; Lehericy S; Hartmann A; Poupon C
    Brain; 2015 Feb; 138(Pt 2):472-82. PubMed ID: 25392196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional immaturity of cortico-basal ganglia networks in Gilles de la Tourette syndrome.
    Worbe Y; Malherbe C; Hartmann A; Pélégrini-Issac M; Messé A; Vidailhet M; Lehéricy S; Benali H
    Brain; 2012 Jun; 135(Pt 6):1937-46. PubMed ID: 22434213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in metabolite concentrations in tourette's disorder and obsessive-compulsive disorder-A proton magnetic resonance spectroscopy study.
    Fan S; Cath DC; van den Heuvel OA; van der Werf YD; Schöls C; Veltman DJ; Pouwels PJW
    Psychoneuroendocrinology; 2017 Mar; 77():211-217. PubMed ID: 28104554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome.
    Worbe Y; Gerardin E; Hartmann A; Valabrégue R; Chupin M; Tremblay L; Vidailhet M; Colliot O; Lehéricy S
    Brain; 2010 Dec; 133(Pt 12):3649-60. PubMed ID: 20959309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H-magnetic resonance spectroscopy study of glutamate-related abnormality in bipolar disorder.
    Kubo H; Nakataki M; Sumitani S; Iga JI; Numata S; Kameoka N; Watanabe SY; Umehara H; Kinoshita M; Inoshita M; Tamaru M; Ohta M; Nakayama-Yamauchi C; Funakoshi Y; Harada M; Ohmori T
    J Affect Disord; 2017 Jan; 208():139-144. PubMed ID: 27770643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural changes in the somatosensory system correlate with tic severity in Gilles de la Tourette syndrome.
    Thomalla G; Siebner HR; Jonas M; Bäumer T; Biermann-Ruben K; Hummel F; Gerloff C; Müller-Vahl K; Schnitzler A; Orth M; Münchau A
    Brain; 2009 Mar; 132(Pt 3):765-77. PubMed ID: 19136548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder.
    Soeiro-de-Souza MG; Henning A; Machado-Vieira R; Moreno RA; Pastorello BF; da Costa Leite C; Vallada H; Otaduy MC
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2221-9. PubMed ID: 26476706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered modulation of intracortical excitability during movement preparation in Gilles de la Tourette syndrome.
    Heise KF; Steven B; Liuzzi G; Thomalla G; Jonas M; Müller-Vahl K; Sauseng P; Münchau A; Gerloff C; Hummel FC
    Brain; 2010 Feb; 133(Pt 2):580-90. PubMed ID: 20008030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional distributions of brain glutamate and glutamine in normal subjects.
    Goryawala MZ; Sheriff S; Maudsley AA
    NMR Biomed; 2016 Aug; 29(8):1108-16. PubMed ID: 27351339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal relationship between premonitory urges and tics in Gilles de la Tourette syndrome.
    Brandt VC; Beck C; Sajin V; Baaske MK; Bäumer T; Beste C; Anders S; Münchau A
    Cortex; 2016 Apr; 77():24-37. PubMed ID: 26922503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putting the Pieces Together in Gilles de la Tourette Syndrome: Exploring the Link Between Clinical Observations and the Biological Basis of Dysfunction.
    Hashemiyoon R; Kuhn J; Visser-Vandewalle V
    Brain Topogr; 2017 Jan; 30(1):3-29. PubMed ID: 27783238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional studies of Gilles de la Tourette syndrome.
    Chase TN; Geoffrey V; Gillespie M; Burrows GH
    Rev Neurol (Paris); 1986; 142(11):851-5. PubMed ID: 2881340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitter activity is linked to outcome following subthalamic deep brain stimulation in Parkinson's disease.
    O'Gorman Tuura RL; Baumann CR; Baumann-Vogel H
    Parkinsonism Relat Disord; 2018 May; 50():54-60. PubMed ID: 29472099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered structure of cortical sulci in gilles de la Tourette syndrome: Further support for abnormal brain development.
    Muellner J; Delmaire C; Valabrégue R; Schüpbach M; Mangin JF; Vidailhet M; Lehéricy S; Hartmann A; Worbe Y
    Mov Disord; 2015 Apr; 30(5):655-61. PubMed ID: 25820811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Movement lateralization and bimanual coordination in children with Tourette syndrome.
    Avanzino L; Martino D; Bove M; De Grandis E; Tacchino A; Pelosin E; Mirabelli M; Veneselli E; Abbruzzese G
    Mov Disord; 2011 Sep; 26(11):2114-8. PubMed ID: 21932301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced habit formation in Gilles de la Tourette syndrome.
    Delorme C; Salvador A; Valabrègue R; Roze E; Palminteri S; Vidailhet M; de Wit S; Robbins T; Hartmann A; Worbe Y
    Brain; 2016 Feb; 139(Pt 2):605-15. PubMed ID: 26490329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of
    Nakahara T; Tsugawa S; Noda Y; Ueno F; Honda S; Kinjo M; Segawa H; Hondo N; Mori Y; Watanabe H; Nakahara K; Yoshida K; Wada M; Tarumi R; Iwata Y; Plitman E; Moriguchi S; de la Fuente-Sandoval C; Uchida H; Mimura M; Graff-Guerrero A; Nakajima S
    Mol Psychiatry; 2022 Jan; 27(1):744-757. PubMed ID: 34584230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased thalamic glutamate/glutamine levels in migraineurs.
    Bathel A; Schweizer L; Stude P; Glaubitz B; Wulms N; Delice S; Schmidt-Wilcke T
    J Headache Pain; 2018 Jul; 19(1):55. PubMed ID: 30019230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.